DSHEA: The Dietary Supplement Health and Education Act of 1994 Explained

If you buy, sell, or distribute supplements in the United States, you are working inside a framework built by DSHEA, the Dietary Supplement Health and Education Act. Signed into law on October 25, 1994, it amended the Federal Food, Drug, and Cosmetic Act to create a distinct regulatory category for dietary supplements, separate from both conventional foods and drugs.

Three decades later, the basic structure is still in place. Understanding it explains why supplements do not need FDA approval before sale, why the label disclaimer exists, and why certain new ingredients require a filing with FDA while others do not.

Why DSHEA 1994 Was Passed

In the late 1980s and early 1990s, the legal status of supplements was unsettled. FDA had tried at various points to treat some high-potency vitamins and certain ingredients as food additives or drugs, and the Nutrition Labeling and Education Act of 1990 raised questions about how health-related statements would apply to supplements. Industry groups and consumers pushed back, and Congress received a heavy volume of public comment on the issue.

DSHEA 1994 was the result. Its findings stated that supplements could have benefits for health and that consumers should have access to them along with truthful information. The law tried to balance that access with FDA's authority to remove unsafe products.

What the Dietary Supplement Health and Education Act Does

DSHEA is not long, but it touches almost every part of how supplements are made, labeled, and sold. There is no single rulebook titled 'DSHEA guidelines'; instead, the statute set the framework and FDA has filled in details through regulations and guidance documents over the years. The core provisions fall into a handful of areas.

The definition

Under DSHEA, a dietary supplement is a product intended to supplement the diet that contains one or more dietary ingredients: a vitamin, mineral, herb or other botanical, amino acid, a dietary substance to increase total dietary intake, or a concentrate, metabolite, constituent, extract, or combination of these. It must be intended for ingestion, labeled as a dietary supplement, and not represented as a conventional food or the sole item of a meal.

Safety and the burden of proof

DSHEA did not create pre-market approval for supplements. Manufacturers and distributors are responsible for making sure their products are safe and properly labeled before they reach the market, and FDA acts after the fact when it finds a problem. In practice, FDA carries the burden of showing that a supplement is adulterated. The best-known use of this authority was FDA's 2004 rule declaring supplements containing ephedrine alkaloids adulterated, which was upheld in federal court.

New dietary ingredients

Ingredients marketed in the U.S. before October 15, 1994 are often called old dietary ingredients. For a new dietary ingredient, the manufacturer or distributor generally must notify FDA at least 75 days before marketing and provide the basis for concluding the ingredient will reasonably be expected to be safe. The main exception applies when the ingredient has been present in the food supply as an article used for food in a form that has not been chemically altered. FDA has issued guidance on NDI notifications over the years, and the question of what counts as an old ingredient remains a live issue.

Claims and the disclaimer

DSHEA authorized statements of nutritional support, now usually called structure/function claims, as long as they are truthful and not misleading, FDA is notified within 30 days, and the label carries the required disclaimer. Our article on the FDA supplement disclaimer covers the wording and placement rules.

What DSHEA Created Beyond the Rules

The law also established the Office of Dietary Supplements at the National Institutes of Health to support and coordinate research, and it created a Commission on Dietary Supplement Labels, which issued its report in 1997. The ODS remains a widely used source of ingredient fact sheets.

How the Law Has Been Updated

DSHEA has been amended and built on rather than replaced. The key additions:

• 2006: The Dietary Supplement and Nonprescription Drug Consumer Protection Act required companies to report serious adverse events to FDA and to put a domestic contact on the label.
• 2007: FDA published the dietary supplement cGMP rule, 21 CFR Part 111, using the authority DSHEA granted. See our plain-English guide to 21 CFR 111.
• 2011: The Food Safety Modernization Act gave FDA mandatory recall authority over foods, including supplements, and directed the agency to clarify NDI requirements.

Proposals to add mandatory product listing and other reforms have been debated in Congress in recent years. Buyers should watch this area, because changes to listing or registration requirements would affect what documentation suppliers need to provide.

DSHEA gave supplements market access without pre-approval, and in exchange it put the responsibility for safety and truthful labeling squarely on the companies that sell them.

What DSHEA Means for Buyers Today

Because supplements are not approved before sale, the quality controls a buyer can see come from the supply chain itself. That is why experienced buyers ask for evidence of cGMP compliance, third-party audits, and lot-specific certificates of analysis rather than assuming a product on the market has been vetted by FDA. It is also why label review matters: the claims on a product are the company's responsibility, and a retailer carrying a product with disease claims shares the exposure.

RV Pharma distributes supplements that are made under cGMP, NSF/ANSI 455-2, third-party tested, and FDA registered, with lot-specific COAs available on request. The Buyer Resources page includes a redacted sample COA if you want to see the documentation format before ordering.